
Spiroglumide
CAS No. 137795-35-8
Spiroglumide ( —— )
产品货号. M36133 CAS No. 137795-35-8
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥2041 | 有现货 |
![]() ![]() |
5MG | ¥3149 | 有现货 |
![]() ![]() |
10MG | ¥4764 | 有现货 |
![]() ![]() |
25MG | ¥7374 | 有现货 |
![]() ![]() |
50MG | ¥10010 | 有现货 |
![]() ![]() |
100MG | ¥13235 | 有现货 |
![]() ![]() |
500MG | ¥26469 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Spiroglumide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
-
产品描述Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
-
体外实验——
-
体内实验——
-
同义词——
-
通路GPCR/G Protein
-
靶点Cholecystokinin Receptor
-
受体cholecystokinin
-
研究领域——
-
适应症——
化学信息
-
CAS Number137795-35-8
-
分子量441.35
-
分子式C21H26Cl2N2O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC([C@H](NC(=O)C1=CC(Cl)=CC(Cl)=C1)CCC(O)=O)(=O)N2CCC3(CC2)CCCC3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
JNJ-26070109
一种新型、有效、选择性口服活性 CCK-2 受体拮抗剂,hCCK2 的 pKi 为 8.49。
-
Spiroglumide
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
-
Gastrin I, human
胃中产生的内源性肽,通过 CCK2 受体增加胃酸的分泌。